Orosur files 43-101 technical report for its Anza Project in Colombia LONDON, UK / ACCESS Newswire / March 26, 2026 / Orosur Mining Inc. (" Orosur " or the " Company ") (TSXV:OMI)(AIM:OMI) , is pleased to announce the filing of a National Instrument 43-101 - Standards of Disclosure for Mineral Projects - compliant technical report in support of the Company's 100%-owned Anza Project in Colombia including its maiden Mineral Resource Estimate for the Pepas deposit. Effective date of the report is 16 th January 2026, and issue date is 25 th March 2026.
LONDON, UK / ACCESS Newswire / February 27, 2026 / Orosur Mining Inc. ("Orosur" or "the Company") (AIM:OMI)(TSXV:OMI), a minerals explorer and developer with projects in Colombia and Argentina, advises that during February 2026, the Company has issued 1,316,949 new common shares of no par value each ("Common Shares") for a total consideration of US$110,703 following the exercise of 1,016,949 warrants at a price of US$0.0558 and 300,000 warrants at a price of Cdn$0.25 respectively from its block listing announced January 14, 2026. For the purposes of the Disclosure Guidance and Transparency Rules, the Company has 394,547,125 Common Shares in issue.
Owens and Minor (NYSE: OMI - Get Free Report) and RBC Life Sciences (OTCMKTS:RBCL - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings. Profitability This table compares Owens and
LONDON, UNITED KINGDOM / ACCESS Newswire / January 30, 2026 / Orosur Mining Inc. ("Orosur" or "the Company") (TSXV:OMI)(AIM:OMI) , a minerals explorer and developer with projects in Colombia and Argentina, advises that during January 2026, the Company has issued 1,857,949 new common shares of no par value each ("Common Shares") for a total consideration of US$286,160 following the exercise of 1,471,000 warrants at a price of Cdn$0.25 and 386,949 warrants at a price of US$0.0558 respectively from its block listing announced January 14, 2026. For the purposes of the Disclosure Guidance and Transparency Rules, the Company has 394,547,125 Common Shares in issue.
Orosur Mining Inc (AIM:OMI, TSX-V:OMI) shares gained 8% after an update which outlined exploration activity, which highlighted that infill drilling continued at its Pepas gold prospect in Anzá as it works toward a NI 43-101 compliant mineral resource estimate. Orosur said: “As anticipated, drilling results have firmed up the Pepas deposit and provided a better definition of the nature of the thick, high-grade mineralisation.
LONDON, UK / ACCESS Newswire / January 26, 2026 / Orosur Mining Inc. ("Orosur" or "the Company") (TSX-V:OMI)(AIM:OMI) the minerals developer and explorer with operations in Colombia and Argentina, announces its unaudited results for the quarter ended November 30th, 2025. All dollar figures are stated in US$ unless otherwise noted.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. “Today's announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform. The completio.
LONDON, UK / ACCESS Newswire / December 31, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (AIM:OMI)(TSXV:OMI), a minerals explorer and developer with projects in Colombia and Argentina, advises that, following the Admission of 666,664 common shares of no par value ("Common Shares") on 16 December 2025 pursuant to the exercise of options by consultants of the Company, as announced on 15 December 2025, the Company has 392,689,176 Common Shares in issue. There were no warrants exercised and therefore no Common Shares issued during December from the Company's block listing.
Owens and Minor (NYSE: OMI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Volatility and Risk Owens and Minor has
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (“the Company”) today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company's strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare.
